A protein that may help brain tumor cells grow
Original title: The Expression and Oncogenic Role of NTSR2 in Human Glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice.
The short version
Scientists found a protein that seems to help glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary cells grow and spread.
What was studied. Researchers studied brain tumor tissue and glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary cells grown in the lab. They also lowered the protein in mice that had brain tumors.
What they found. The protein, called NTSR2, was found at lower levels in glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary tissue. Even so, in lab cells it helped the tumor cells grow, move, and spread. It also kept those cells from dying. When the team turned the protein down in mice, the brain tumors grew much less.
What this means, and what it doesn't
What it could mean: This may point to a new target for drugs someday. It does not change any care a patient can get now.
What it doesn't mean: This work was done only in lab cells and in mice. It is not a treatment, and it is not a cure. No one has tried it in people yet. Many more years of study would be needed first, and most early findings like this never become a therapy.
Source: PubMed, September 25, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.